Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

DARTseq identifies m6A targets in human CD34+ HSPCs

ABSTRACT: DARTseq identifies m6A targets in human CD34+ HSPCs

PROVIDER: PRJNA968169 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

DARTseq identifies m6A targets in human CD34+ HSPCs

Project description:The goal of this study is to identify m6A targets in human CD34+ HSPCs with or without STM2457 treatment using DARTseq. Purified human CD34+ HSPC cells were transduced with APOBEC-YTH or empty vector control (MIG). 24hr post infection, CD34+ cells were treated with STM2457 at a concentration of 20µM for 2 days. GFP+ cells were sorted the next day. 3 replicates were performed.

2023-12-07 | GSE231861 | GEO

DARTseq identifies m6A targets in mouse primary cells

Project description:DARTseq identifies m6A targets in mouse primary cells

| PRJNA968168 | ENA

Homo sapiens isolate:CD34+ HSPCs

Project description:Off-target deep sequencing of FLT3, CD123, KIT epitope-edited CD34+ HSPCs

| PRJNA986845 | ENA

RNA-seq on DMSO and EPZ6438 treated CD34+ HSPCs

Project description:The overall goal is to understand how does the DNA methylation Canyon interactions in CD34+ HSPCs can be impacted by the inhibition of EZH2

2020-01-24 | GSE144131 | GEO

In Situ on DMSO and EPZ6438 treated CD34+ HSPCs

Project description:The overall goal is to understand how does the DNA methylation Canyon interactions in CD34+ HSPCs can be impacted by the inhibition of EZH2

2020-01-24 | GSE144126 | GEO

Transcriptome of CBX7 and CBX8 overexpressing CD34+ HSPCs

Project description:Transcriptome of CBX7 and CBX8 overexpressing CD34+ HSPCs

| PRJEB22831 | ENA

Transcriptome profiling of quiescent and cytokine induced normal human haematopoietic CD34+ HSPCs, and AML blast cells

Project description:Control group is an essential part of the research design which provide a baseline by elimating variables, bias and other factors that skew the data. Human CD34+ cells are generally used as controls to study myeloid malignancies. This study determines whether fresh or short term cytokine induced CD34+ HSPCs can provide a more appropriate normal control (compared to AML blasts) for target discovery studies. We here determine that the GEP of CD34+ cells that do not undergo ex vivo expansion best match the GEP of minimally differentiated AML blasts and would serve as a better control to identify novel targets in the AML blast population.

2015-12-09 | E-MTAB-3328 | biostudies-arrayexpress

m6A-seq mapping of human umbilical cord blood hematopoietic stem/progenitor cells

Project description:We performed m6A-seq analysis with CD34+ human umblilical cord blood HSPCs

2018-08-17 | GSE107954 | GEO

H3K27me3 and H3K4me3 ChIP-seq on DMSO and EPZ6438 treated CD34+ HSPCs

Project description:The overall goal is to understand how does the DNA methylation Canyon interactions in CD34+ HSPCs can be impacted by the inhibition of EZH2

2020-01-24 | GSE144124 | GEO

RNA-seq on DMSO and EPZ6438 treated CD34+ HSPCs

Project description:RNA-seq on DMSO and EPZ6438 treated CD34+ HSPCs

| PRJNA602869 | ENA